Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
von Willebrand Factor | 34 | 2003 | 676 | 1.720 |
Why?
|
Platelet Membrane Glycoproteins | 21 | 1996 | 284 | 1.070 |
Why?
|
Blood Platelets | 50 | 2011 | 2478 | 0.900 |
Why?
|
Platelet Glycoprotein GPIb-IX Complex | 9 | 2003 | 144 | 0.830 |
Why?
|
Zebrafish | 12 | 2022 | 3005 | 0.630 |
Why?
|
Platelet Membrane Glycoprotein IIb | 3 | 2017 | 51 | 0.490 |
Why?
|
Vitamin K | 1 | 2016 | 313 | 0.450 |
Why?
|
Heparin | 11 | 2016 | 1632 | 0.410 |
Why?
|
Platelet Factor 4 | 13 | 1989 | 129 | 0.390 |
Why?
|
Platelet Aggregation | 24 | 2003 | 771 | 0.360 |
Why?
|
Blood Coagulation Factors | 11 | 1985 | 366 | 0.350 |
Why?
|
Prostaglandins | 10 | 1983 | 398 | 0.340 |
Why?
|
Blood Platelet Disorders | 2 | 2005 | 60 | 0.320 |
Why?
|
Collagen | 10 | 1997 | 2634 | 0.310 |
Why?
|
Fibrinolytic Agents | 3 | 2016 | 2073 | 0.300 |
Why?
|
von Willebrand Diseases | 5 | 2005 | 132 | 0.290 |
Why?
|
Polymorphism, Restriction Fragment Length | 4 | 1992 | 767 | 0.280 |
Why?
|
Aspirin | 9 | 2016 | 3127 | 0.270 |
Why?
|
Epoprostenol | 10 | 1996 | 247 | 0.260 |
Why?
|
Hematopoietic Stem Cells | 3 | 2017 | 3394 | 0.240 |
Why?
|
Thrombopoiesis | 1 | 2005 | 164 | 0.220 |
Why?
|
Hemophilia A | 3 | 2022 | 359 | 0.210 |
Why?
|
Hermanski-Pudlak Syndrome | 1 | 2022 | 20 | 0.200 |
Why?
|
Hemostatics | 2 | 2022 | 240 | 0.190 |
Why?
|
Antibodies, Bispecific | 1 | 2022 | 196 | 0.170 |
Why?
|
Platelet Adhesiveness | 7 | 1996 | 154 | 0.170 |
Why?
|
Helicobacter pylori | 1 | 2003 | 381 | 0.170 |
Why?
|
Flow Cytometry | 6 | 2017 | 5863 | 0.160 |
Why?
|
Chromosomes, Human, Pair 12 | 2 | 1990 | 430 | 0.160 |
Why?
|
Zebrafish Proteins | 3 | 2017 | 1013 | 0.150 |
Why?
|
Bernard-Soulier Syndrome | 2 | 2005 | 7 | 0.150 |
Why?
|
Megakaryocytes | 3 | 1996 | 566 | 0.150 |
Why?
|
Blood Preservation | 5 | 1988 | 169 | 0.150 |
Why?
|
Ristocetin | 8 | 1995 | 26 | 0.140 |
Why?
|
Endothelium, Vascular | 5 | 1995 | 4433 | 0.140 |
Why?
|
Vascular Endothelial Growth Factor D | 1 | 2016 | 63 | 0.140 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 2017 | 94 | 0.140 |
Why?
|
Pregnancy Complications, Hematologic | 2 | 2017 | 180 | 0.140 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 1998 | 344 | 0.130 |
Why?
|
Fibrinolysin | 3 | 1986 | 131 | 0.130 |
Why?
|
Glycoproteins | 6 | 1986 | 2200 | 0.130 |
Why?
|
Cell Line | 11 | 2016 | 15577 | 0.130 |
Why?
|
Antithrombins | 1 | 1998 | 292 | 0.130 |
Why?
|
Animals, Genetically Modified | 3 | 2011 | 1557 | 0.130 |
Why?
|
Arachidonic Acids | 5 | 1983 | 294 | 0.130 |
Why?
|
Bone Marrow Diseases | 1 | 2017 | 233 | 0.120 |
Why?
|
Anemia, Aplastic | 1 | 2017 | 230 | 0.120 |
Why?
|
Prostaglandins D | 3 | 1979 | 27 | 0.120 |
Why?
|
Prescription Fees | 1 | 2015 | 153 | 0.110 |
Why?
|
Purpura, Thrombocytopenic | 6 | 1981 | 41 | 0.110 |
Why?
|
History, 19th Century | 1 | 2016 | 718 | 0.110 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2017 | 693 | 0.110 |
Why?
|
Binding Sites | 10 | 2000 | 6051 | 0.110 |
Why?
|
Embryonic Development | 2 | 2009 | 720 | 0.110 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 1996 | 577 | 0.110 |
Why?
|
Green Fluorescent Proteins | 2 | 2011 | 2063 | 0.110 |
Why?
|
Patient Advocacy | 1 | 2015 | 360 | 0.110 |
Why?
|
Fibrin | 3 | 1986 | 507 | 0.110 |
Why?
|
Cloning, Molecular | 6 | 2007 | 4172 | 0.100 |
Why?
|
Molecular Sequence Data | 11 | 2007 | 17630 | 0.100 |
Why?
|
Embryo, Nonmammalian | 3 | 2011 | 905 | 0.100 |
Why?
|
Coronary Disease | 4 | 1996 | 5911 | 0.100 |
Why?
|
Kinetics | 13 | 1992 | 6370 | 0.100 |
Why?
|
Regeneration | 2 | 2011 | 1505 | 0.100 |
Why?
|
Catecholamines | 3 | 1981 | 387 | 0.100 |
Why?
|
Ticlopidine | 1 | 1996 | 730 | 0.090 |
Why?
|
Genes | 3 | 1990 | 1823 | 0.090 |
Why?
|
Recombinant Proteins | 9 | 2000 | 6520 | 0.090 |
Why?
|
Receptors, Cell Surface | 4 | 1996 | 2802 | 0.090 |
Why?
|
Adenosine Diphosphate | 5 | 1992 | 422 | 0.090 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 1992 | 418 | 0.090 |
Why?
|
Neoplasms, Experimental | 1 | 2016 | 1226 | 0.090 |
Why?
|
Transforming Growth Factors | 1 | 1990 | 75 | 0.090 |
Why?
|
Cell Adhesion | 6 | 2000 | 3088 | 0.090 |
Why?
|
History, 21st Century | 1 | 2016 | 1566 | 0.090 |
Why?
|
Gamma Rays | 1 | 2011 | 318 | 0.090 |
Why?
|
Mutagenesis, Site-Directed | 2 | 1997 | 1692 | 0.080 |
Why?
|
Nephrons | 1 | 2011 | 168 | 0.080 |
Why?
|
Base Sequence | 9 | 1997 | 12420 | 0.080 |
Why?
|
Blood Coagulation Disorders | 3 | 2005 | 350 | 0.080 |
Why?
|
Membrane Proteins | 6 | 1986 | 7847 | 0.080 |
Why?
|
Leukemia, Megakaryoblastic, Acute | 1 | 1988 | 48 | 0.080 |
Why?
|
Gene Expression Regulation, Developmental | 3 | 2009 | 3606 | 0.080 |
Why?
|
Thrombocytopenia | 4 | 2005 | 1182 | 0.080 |
Why?
|
Humans | 100 | 2022 | 760740 | 0.080 |
Why?
|
In Situ Hybridization | 3 | 2009 | 1900 | 0.080 |
Why?
|
History, 20th Century | 1 | 2016 | 2764 | 0.080 |
Why?
|
Angina Pectoris | 3 | 1981 | 959 | 0.080 |
Why?
|
Vascular Diseases | 1 | 2016 | 1159 | 0.080 |
Why?
|
Bone Marrow Cells | 1 | 2016 | 2409 | 0.080 |
Why?
|
Polymorphism, Genetic | 2 | 1996 | 4242 | 0.080 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2010 | 618 | 0.070 |
Why?
|
Antigens, Surface | 2 | 1992 | 1606 | 0.070 |
Why?
|
Animals | 36 | 2022 | 168202 | 0.070 |
Why?
|
Blood Vessels | 3 | 2010 | 1112 | 0.070 |
Why?
|
Integrin alphaV | 1 | 2007 | 54 | 0.070 |
Why?
|
Drug Costs | 1 | 2015 | 1183 | 0.070 |
Why?
|
Integrin beta3 | 1 | 2007 | 120 | 0.070 |
Why?
|
Integrin alphaVbeta3 | 1 | 2007 | 105 | 0.070 |
Why?
|
Hematopoiesis, Extramedullary | 1 | 2006 | 53 | 0.070 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 3 | 1992 | 166 | 0.070 |
Why?
|
Hematopoietic System | 1 | 2006 | 110 | 0.070 |
Why?
|
Endothelium | 8 | 1987 | 764 | 0.070 |
Why?
|
Oxygen Consumption | 3 | 1982 | 1866 | 0.070 |
Why?
|
Tail | 1 | 2006 | 91 | 0.070 |
Why?
|
Pregnancy Outcome | 1 | 2017 | 2921 | 0.070 |
Why?
|
Lung Diseases | 1 | 2016 | 1909 | 0.070 |
Why?
|
Muscle, Smooth, Vascular | 3 | 1985 | 1492 | 0.070 |
Why?
|
Oligopeptides | 1 | 1992 | 1185 | 0.070 |
Why?
|
Factor VIII | 2 | 2022 | 348 | 0.070 |
Why?
|
Patient Participation | 1 | 2015 | 1443 | 0.070 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 1996 | 2746 | 0.060 |
Why?
|
Blood Coagulation | 5 | 1981 | 1154 | 0.060 |
Why?
|
Phagocytosis | 3 | 1978 | 1526 | 0.060 |
Why?
|
Receptors, Collagen | 1 | 2005 | 25 | 0.060 |
Why?
|
Thrombasthenia | 1 | 2005 | 21 | 0.060 |
Why?
|
Thromboembolism | 5 | 1981 | 991 | 0.060 |
Why?
|
Mitosis | 1 | 1990 | 1187 | 0.060 |
Why?
|
Blood Cell Count | 9 | 1982 | 397 | 0.060 |
Why?
|
Receptors, Adrenergic, alpha | 3 | 1982 | 146 | 0.060 |
Why?
|
Receptors, Adrenergic | 3 | 1982 | 155 | 0.060 |
Why?
|
Hematopoiesis | 2 | 2011 | 2049 | 0.060 |
Why?
|
Protein Binding | 8 | 1998 | 9345 | 0.060 |
Why?
|
Aorta | 2 | 1983 | 2041 | 0.060 |
Why?
|
Protein Conformation | 5 | 2000 | 3965 | 0.060 |
Why?
|
Glycosaminoglycans | 2 | 1985 | 607 | 0.060 |
Why?
|
Stents | 1 | 1996 | 3177 | 0.060 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2006 | 661 | 0.060 |
Why?
|
Hematologic Neoplasms | 1 | 2016 | 1896 | 0.060 |
Why?
|
Signal Transduction | 5 | 2016 | 23415 | 0.060 |
Why?
|
Cell Differentiation | 6 | 2011 | 11512 | 0.050 |
Why?
|
Prostaglandins E | 3 | 1981 | 166 | 0.050 |
Why?
|
Neovascularization, Physiologic | 1 | 2010 | 1349 | 0.050 |
Why?
|
Cross-Linking Reagents | 1 | 1986 | 685 | 0.050 |
Why?
|
Thromboxane A2 | 2 | 1991 | 88 | 0.050 |
Why?
|
Cyclic AMP | 4 | 1981 | 1463 | 0.050 |
Why?
|
Lipoxygenase | 1 | 1982 | 72 | 0.050 |
Why?
|
Albinism | 1 | 2022 | 25 | 0.050 |
Why?
|
Cytoplasmic Granules | 2 | 2005 | 573 | 0.050 |
Why?
|
Nonmuscle Myosin Type IIB | 1 | 2022 | 21 | 0.050 |
Why?
|
Erythropoietin | 1 | 2007 | 719 | 0.050 |
Why?
|
Hemostasis | 3 | 1990 | 469 | 0.050 |
Why?
|
Mutagenesis | 2 | 2000 | 1230 | 0.050 |
Why?
|
Hemorrhagic Disorders | 1 | 2022 | 34 | 0.050 |
Why?
|
Oligodeoxyribonucleotides | 2 | 1995 | 704 | 0.050 |
Why?
|
Guaifenesin | 2 | 1978 | 5 | 0.050 |
Why?
|
Receptors, Angiotensin | 1 | 2022 | 141 | 0.050 |
Why?
|
Antibodies | 5 | 1978 | 2413 | 0.050 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 3 | 1992 | 1738 | 0.050 |
Why?
|
Binding, Competitive | 5 | 1986 | 1141 | 0.050 |
Why?
|
Chlorpromazine | 2 | 1978 | 111 | 0.050 |
Why?
|
Peptic Ulcer | 1 | 2003 | 217 | 0.050 |
Why?
|
Precipitin Tests | 2 | 1993 | 813 | 0.050 |
Why?
|
DNA | 9 | 1992 | 7196 | 0.050 |
Why?
|
Diphenhydramine | 2 | 1978 | 63 | 0.050 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 1982 | 318 | 0.050 |
Why?
|
Thromboxanes | 1 | 1981 | 45 | 0.050 |
Why?
|
Angina Pectoris, Variant | 1 | 1981 | 53 | 0.050 |
Why?
|
Protein Precursors | 5 | 1989 | 1131 | 0.050 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2005 | 2747 | 0.050 |
Why?
|
Thrombophlebitis | 2 | 1979 | 289 | 0.050 |
Why?
|
Prothrombin | 1 | 1981 | 190 | 0.050 |
Why?
|
Macromolecular Substances | 5 | 1997 | 1433 | 0.050 |
Why?
|
Neoplastic Stem Cells | 1 | 1988 | 1350 | 0.040 |
Why?
|
Crystallography, X-Ray | 3 | 2000 | 1989 | 0.040 |
Why?
|
Losartan | 1 | 2022 | 263 | 0.040 |
Why?
|
Anticoagulants | 1 | 1996 | 4785 | 0.040 |
Why?
|
Graft Survival | 1 | 2011 | 3814 | 0.040 |
Why?
|
Amino Acid Sequence | 7 | 2007 | 13442 | 0.040 |
Why?
|
Ventricular Fibrillation | 1 | 1983 | 534 | 0.040 |
Why?
|
Adrenergic beta-Agonists | 1 | 1981 | 346 | 0.040 |
Why?
|
Coronary Circulation | 2 | 1983 | 1569 | 0.040 |
Why?
|
Dihydroergotoxine | 2 | 1978 | 21 | 0.040 |
Why?
|
Helicobacter Infections | 1 | 2003 | 391 | 0.040 |
Why?
|
Leukocytes | 3 | 1978 | 2024 | 0.040 |
Why?
|
Receptors, Prostaglandin | 1 | 1979 | 53 | 0.040 |
Why?
|
Microscopy, Confocal | 1 | 2005 | 1970 | 0.040 |
Why?
|
Maternal-Fetal Exchange | 1 | 1981 | 461 | 0.040 |
Why?
|
Cattle | 4 | 1989 | 3841 | 0.040 |
Why?
|
Mentors | 1 | 2004 | 661 | 0.040 |
Why?
|
Nitroglycerin | 1 | 1980 | 329 | 0.040 |
Why?
|
Carbohydrate Sequence | 2 | 1992 | 411 | 0.040 |
Why?
|
Thrombin | 2 | 1998 | 592 | 0.040 |
Why?
|
Cell Transformation, Viral | 1 | 1980 | 526 | 0.040 |
Why?
|
Genes, Dominant | 2 | 1992 | 851 | 0.040 |
Why?
|
Epinephrine | 6 | 1982 | 792 | 0.040 |
Why?
|
Platelet Activation | 2 | 1992 | 646 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2016 | 5144 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4569 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 4 | 1992 | 2467 | 0.040 |
Why?
|
Lactation Disorders | 1 | 2017 | 14 | 0.040 |
Why?
|
Stem Cells | 1 | 2011 | 3514 | 0.040 |
Why?
|
Kidney | 2 | 2011 | 7044 | 0.040 |
Why?
|
Cells, Cultured | 9 | 1992 | 18937 | 0.040 |
Why?
|
Factor XII | 1 | 1977 | 19 | 0.040 |
Why?
|
Indomethacin | 4 | 1983 | 323 | 0.040 |
Why?
|
Heart | 1 | 2010 | 4403 | 0.040 |
Why?
|
Umbilical Veins | 3 | 1990 | 426 | 0.040 |
Why?
|
Internal Medicine | 1 | 2004 | 1051 | 0.040 |
Why?
|
False Negative Reactions | 2 | 2017 | 573 | 0.030 |
Why?
|
Physical Exertion | 1 | 1980 | 668 | 0.030 |
Why?
|
Prednisone | 1 | 1981 | 1562 | 0.030 |
Why?
|
Chediak-Higashi Syndrome | 1 | 1976 | 10 | 0.030 |
Why?
|
Chromatography, Gel | 2 | 1992 | 645 | 0.030 |
Why?
|
Leukemia | 1 | 1985 | 1520 | 0.030 |
Why?
|
Factor VII | 1 | 1976 | 139 | 0.030 |
Why?
|
Temperature | 5 | 1984 | 2224 | 0.030 |
Why?
|
Spectrometry, Fluorescence | 3 | 1985 | 685 | 0.030 |
Why?
|
Infant, Newborn, Diseases | 1 | 1981 | 589 | 0.030 |
Why?
|
Superoxides | 1 | 1977 | 387 | 0.030 |
Why?
|
Antibody Specificity | 2 | 1984 | 1057 | 0.030 |
Why?
|
Veins | 1 | 1980 | 767 | 0.030 |
Why?
|
Fetal Death | 1 | 2017 | 435 | 0.030 |
Why?
|
Transfection | 3 | 1992 | 5765 | 0.030 |
Why?
|
Malondialdehyde | 3 | 1980 | 112 | 0.030 |
Why?
|
Models, Molecular | 3 | 2000 | 5433 | 0.030 |
Why?
|
Radioimmunoassay | 3 | 1981 | 861 | 0.030 |
Why?
|
Molecular Weight | 3 | 1986 | 2185 | 0.030 |
Why?
|
Rabbits | 5 | 1985 | 4770 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17878 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2009 | 5789 | 0.030 |
Why?
|
Chickens | 1 | 2016 | 858 | 0.030 |
Why?
|
DNA Primers | 2 | 1997 | 2817 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 1997 | 1229 | 0.030 |
Why?
|
Protein Kinase C | 2 | 1996 | 1202 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 1992 | 3798 | 0.030 |
Why?
|
Angina, Unstable | 1 | 1998 | 888 | 0.030 |
Why?
|
Mathematics | 2 | 1985 | 707 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2005 | 5780 | 0.030 |
Why?
|
Pedigree | 2 | 1993 | 4539 | 0.030 |
Why?
|
DNA, Complementary | 2 | 2007 | 1989 | 0.030 |
Why?
|
Thromboxane B2 | 3 | 1982 | 143 | 0.030 |
Why?
|
Cell Communication | 1 | 1981 | 1654 | 0.030 |
Why?
|
Mutation | 3 | 2016 | 30015 | 0.030 |
Why?
|
Polymerase Chain Reaction | 3 | 2009 | 6074 | 0.030 |
Why?
|
Cell Division | 4 | 1996 | 4457 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2011 | 5671 | 0.030 |
Why?
|
Tetradecanoylphorbol Acetate | 2 | 1996 | 817 | 0.030 |
Why?
|
Fibroblasts | 2 | 2022 | 4140 | 0.030 |
Why?
|
Threonine | 1 | 1993 | 271 | 0.030 |
Why?
|
Infant, Newborn | 4 | 2017 | 26183 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13635 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2016 | 2010 | 0.030 |
Why?
|
Abortion, Spontaneous | 1 | 2017 | 532 | 0.030 |
Why?
|
Telomerase | 1 | 2017 | 744 | 0.030 |
Why?
|
Myeloproliferative Disorders | 1 | 1978 | 611 | 0.020 |
Why?
|
Factor XIII | 2 | 1986 | 59 | 0.020 |
Why?
|
Point Mutation | 2 | 1997 | 1595 | 0.020 |
Why?
|
Isoenzymes | 1 | 1996 | 1687 | 0.020 |
Why?
|
Antigen-Antibody Complex | 1 | 1973 | 509 | 0.020 |
Why?
|
Cell Membrane | 5 | 1992 | 3680 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 2 | 1978 | 1878 | 0.020 |
Why?
|
Escherichia coli | 3 | 1993 | 4210 | 0.020 |
Why?
|
Infertility, Female | 1 | 2017 | 760 | 0.020 |
Why?
|
Lung | 3 | 2022 | 9999 | 0.020 |
Why?
|
Contraceptives, Oral | 1 | 1974 | 553 | 0.020 |
Why?
|
Disulfides | 3 | 1993 | 464 | 0.020 |
Why?
|
Plasmids | 3 | 1992 | 2265 | 0.020 |
Why?
|
Indicators and Reagents | 1 | 1992 | 460 | 0.020 |
Why?
|
Drug Interactions | 2 | 1986 | 1415 | 0.020 |
Why?
|
Isoproterenol | 2 | 1981 | 397 | 0.020 |
Why?
|
Growth Substances | 2 | 1985 | 768 | 0.020 |
Why?
|
Methionine | 1 | 1993 | 572 | 0.020 |
Why?
|
Genes, Recessive | 1 | 1993 | 623 | 0.020 |
Why?
|
Serotonin | 5 | 1978 | 1041 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2004 | 3882 | 0.020 |
Why?
|
Cell Movement | 1 | 2022 | 5201 | 0.020 |
Why?
|
Oligonucleotide Probes | 1 | 1990 | 416 | 0.020 |
Why?
|
Amino Acids | 2 | 1992 | 1718 | 0.020 |
Why?
|
Carbohydrates | 1 | 1992 | 390 | 0.020 |
Why?
|
Oligosaccharides | 1 | 1992 | 406 | 0.020 |
Why?
|
Blood Transfusion | 3 | 1976 | 1300 | 0.020 |
Why?
|
Blotting, Southern | 1 | 1990 | 777 | 0.020 |
Why?
|
Organogenesis | 1 | 2011 | 214 | 0.020 |
Why?
|
DNA Probes | 1 | 1990 | 541 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2016 | 16968 | 0.020 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 1974 | 512 | 0.020 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 1996 | 1723 | 0.020 |
Why?
|
Larva | 1 | 2011 | 509 | 0.020 |
Why?
|
Propranolol | 2 | 1981 | 490 | 0.020 |
Why?
|
Microscopy, Phase-Contrast | 3 | 1974 | 110 | 0.020 |
Why?
|
Myocardial Infarction | 4 | 1998 | 11458 | 0.020 |
Why?
|
Sequence Alignment | 2 | 2007 | 2178 | 0.020 |
Why?
|
Polymers | 2 | 1986 | 1614 | 0.020 |
Why?
|
Gene Expression | 2 | 1992 | 7569 | 0.020 |
Why?
|
Cations, Divalent | 2 | 1996 | 168 | 0.020 |
Why?
|
Fibrinogen | 2 | 1986 | 887 | 0.020 |
Why?
|
GATA1 Transcription Factor | 1 | 2009 | 296 | 0.020 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2009 | 183 | 0.020 |
Why?
|
Blotting, Northern | 1 | 1990 | 1545 | 0.020 |
Why?
|
Ploidies | 1 | 1988 | 285 | 0.020 |
Why?
|
Centrifugation | 1 | 1988 | 122 | 0.020 |
Why?
|
Streptokinase | 2 | 1985 | 186 | 0.020 |
Why?
|
Splenectomy | 3 | 1974 | 389 | 0.020 |
Why?
|
Enzyme Activation | 3 | 1996 | 3591 | 0.020 |
Why?
|
Platelet Count | 2 | 1988 | 780 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 1980 | 2492 | 0.020 |
Why?
|
Peptides | 2 | 1995 | 4354 | 0.020 |
Why?
|
RNA | 1 | 2017 | 2713 | 0.020 |
Why?
|
Immune Sera | 2 | 1980 | 605 | 0.020 |
Why?
|
Aorta, Thoracic | 2 | 1985 | 1096 | 0.020 |
Why?
|
Receptors, Erythropoietin | 1 | 2007 | 144 | 0.020 |
Why?
|
Dogs | 2 | 1983 | 3837 | 0.020 |
Why?
|
Karyotyping | 1 | 1988 | 1171 | 0.020 |
Why?
|
Thrombosis | 2 | 1998 | 2942 | 0.020 |
Why?
|
Blood Coagulation Tests | 4 | 1976 | 271 | 0.020 |
Why?
|
STAT5 Transcription Factor | 1 | 2007 | 265 | 0.020 |
Why?
|
Opsonin Proteins | 2 | 1978 | 144 | 0.020 |
Why?
|
Chromium Radioisotopes | 2 | 1977 | 34 | 0.020 |
Why?
|
Neoplasms | 1 | 2015 | 22131 | 0.020 |
Why?
|
Alkylation | 1 | 1986 | 84 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2016 | 2644 | 0.020 |
Why?
|
Chromosome Mapping | 2 | 1992 | 4611 | 0.020 |
Why?
|
Vertebrates | 1 | 2007 | 227 | 0.020 |
Why?
|
Oxygen | 2 | 1977 | 4226 | 0.020 |
Why?
|
Pericardium | 1 | 2010 | 664 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 1996 | 6305 | 0.020 |
Why?
|
Carrier Proteins | 1 | 1979 | 4937 | 0.020 |
Why?
|
Hypophysectomy | 2 | 1967 | 114 | 0.020 |
Why?
|
Monosaccharides | 1 | 1986 | 66 | 0.020 |
Why?
|
Mercaptoethanol | 1 | 1985 | 62 | 0.020 |
Why?
|
Chromosomes, Human, 6-12 and X | 1 | 1985 | 69 | 0.020 |
Why?
|
Antigens, Differentiation | 1 | 1988 | 908 | 0.020 |
Why?
|
Blood Proteins | 3 | 1986 | 1172 | 0.020 |
Why?
|
Family | 1 | 2016 | 3193 | 0.020 |
Why?
|
Erythroid Cells | 1 | 2007 | 238 | 0.020 |
Why?
|
Immunoelectrophoresis | 2 | 1976 | 94 | 0.020 |
Why?
|
Immunodiffusion | 2 | 1976 | 141 | 0.020 |
Why?
|
Glycoside Hydrolases | 1 | 1986 | 135 | 0.020 |
Why?
|
6-Ketoprostaglandin F1 alpha | 2 | 1983 | 80 | 0.020 |
Why?
|
Factor X | 1 | 1985 | 64 | 0.020 |
Why?
|
Microscopy, Electron | 2 | 1987 | 2561 | 0.020 |
Why?
|
Immunoglobulin G | 5 | 1976 | 4533 | 0.020 |
Why?
|
Histology | 1 | 1964 | 16 | 0.020 |
Why?
|
Carboxypeptidases | 1 | 1985 | 155 | 0.020 |
Why?
|
Cichlids | 1 | 1964 | 10 | 0.020 |
Why?
|
Antithrombin III | 1 | 1985 | 128 | 0.020 |
Why?
|
Transglutaminases | 1 | 1986 | 196 | 0.020 |
Why?
|
Tilapia | 1 | 1964 | 24 | 0.020 |
Why?
|
Antigens | 2 | 1986 | 1441 | 0.020 |
Why?
|
Radioligand Assay | 1 | 1985 | 366 | 0.020 |
Why?
|
beta-Thromboglobulin | 2 | 1981 | 20 | 0.020 |
Why?
|
Fibrinopeptide A | 2 | 1981 | 43 | 0.020 |
Why?
|
Laminin | 1 | 1986 | 408 | 0.010 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2006 | 695 | 0.010 |
Why?
|
Endocytosis | 1 | 1989 | 955 | 0.010 |
Why?
|
Solubility | 1 | 1986 | 1089 | 0.010 |
Why?
|
Solutions | 1 | 1985 | 412 | 0.010 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 1984 | 201 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 1993 | 4110 | 0.010 |
Why?
|
Chemistry | 1 | 1984 | 346 | 0.010 |
Why?
|
Pulmonary Embolism | 4 | 1984 | 2568 | 0.010 |
Why?
|
Histological Techniques | 1 | 1964 | 194 | 0.010 |
Why?
|
Molecular Structure | 1 | 1989 | 1878 | 0.010 |
Why?
|
Chemical Phenomena | 1 | 1984 | 506 | 0.010 |
Why?
|
Arachidonic Acid | 2 | 1983 | 427 | 0.010 |
Why?
|
Models, Animal | 1 | 2011 | 2108 | 0.010 |
Why?
|
Viscera | 1 | 1964 | 138 | 0.010 |
Why?
|
Chromium Isotopes | 3 | 1972 | 28 | 0.010 |
Why?
|
Dextran Sulfate | 1 | 1985 | 258 | 0.010 |
Why?
|
Factor Xa | 1 | 1985 | 166 | 0.010 |
Why?
|
Pregnancy | 4 | 2017 | 29869 | 0.010 |
Why?
|
Circular Dichroism | 1 | 1984 | 344 | 0.010 |
Why?
|
Internship and Residency | 1 | 2004 | 5878 | 0.010 |
Why?
|
Conserved Sequence | 1 | 2007 | 1162 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 1985 | 11735 | 0.010 |
Why?
|
Thermodynamics | 1 | 1985 | 593 | 0.010 |
Why?
|
Scattering, Radiation | 1 | 1985 | 490 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 2 | 1989 | 1971 | 0.010 |
Why?
|
Aminophylline | 1 | 1983 | 41 | 0.010 |
Why?
|
Cardiac Complexes, Premature | 1 | 1983 | 63 | 0.010 |
Why?
|
Erythropoiesis | 1 | 2007 | 684 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2007 | 2261 | 0.010 |
Why?
|
Dextrans | 1 | 1985 | 573 | 0.010 |
Why?
|
Formaldehyde | 1 | 1985 | 357 | 0.010 |
Why?
|
Infant | 2 | 2016 | 36157 | 0.010 |
Why?
|
Fibronectins | 1 | 1986 | 723 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 1973 | 5463 | 0.010 |
Why?
|
Aorta, Abdominal | 1 | 1985 | 625 | 0.010 |
Why?
|
Fishes | 2 | 1967 | 602 | 0.010 |
Why?
|
Isoantigens | 1 | 1985 | 551 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2011 | 1600 | 0.010 |
Why?
|
Phagocytes | 2 | 1974 | 295 | 0.010 |
Why?
|
CHO Cells | 2 | 1996 | 1387 | 0.010 |
Why?
|
Time Factors | 7 | 1996 | 39908 | 0.010 |
Why?
|
Adrenal Glands | 1 | 1964 | 552 | 0.010 |
Why?
|
Lysine | 1 | 1986 | 993 | 0.010 |
Why?
|
Prostaglandins F | 1 | 1981 | 80 | 0.010 |
Why?
|
Acute Disease | 3 | 1985 | 7236 | 0.010 |
Why?
|
Gallic Acid | 1 | 1981 | 24 | 0.010 |
Why?
|
Secretory Rate | 1 | 1981 | 81 | 0.010 |
Why?
|
1-Methyl-3-isobutylxanthine | 1 | 1981 | 100 | 0.010 |
Why?
|
Thymus Gland | 1 | 2006 | 1243 | 0.010 |
Why?
|
Gallbladder | 1 | 1983 | 308 | 0.010 |
Why?
|
Clonidine | 1 | 1982 | 169 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8209 | 0.010 |
Why?
|
Cricetinae | 2 | 1996 | 2424 | 0.010 |
Why?
|
Arteriosclerosis | 1 | 1985 | 1056 | 0.010 |
Why?
|
Extracellular Matrix | 1 | 1989 | 1718 | 0.010 |
Why?
|
Bucladesine | 1 | 1980 | 118 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3776 | 0.010 |
Why?
|
Autoimmune Diseases | 2 | 1984 | 2238 | 0.010 |
Why?
|
Female | 15 | 2017 | 392203 | 0.010 |
Why?
|
Adult | 12 | 2017 | 220995 | 0.010 |
Why?
|
Organoids | 1 | 1987 | 744 | 0.010 |
Why?
|
Prostaglandins, Synthetic | 1 | 1980 | 24 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 1986 | 3074 | 0.010 |
Why?
|
Thymidine | 2 | 1985 | 297 | 0.010 |
Why?
|
Antibodies, Monoclonal | 2 | 1988 | 9171 | 0.010 |
Why?
|
Mucins | 1 | 1983 | 568 | 0.010 |
Why?
|
Male | 14 | 2016 | 360402 | 0.010 |
Why?
|
Electrophysiology | 1 | 1983 | 1262 | 0.010 |
Why?
|
Sulfinpyrazone | 1 | 1979 | 15 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 1986 | 2231 | 0.010 |
Why?
|
Simian virus 40 | 1 | 1980 | 291 | 0.010 |
Why?
|
Dipyridamole | 1 | 1979 | 140 | 0.010 |
Why?
|
Light | 1 | 1985 | 1352 | 0.010 |
Why?
|
Sodium Fluoride | 1 | 1979 | 65 | 0.010 |
Why?
|
Cell Survival | 3 | 1981 | 5780 | 0.010 |
Why?
|
Arterial Occlusive Diseases | 1 | 1983 | 748 | 0.010 |
Why?
|
Nitrates | 1 | 1980 | 263 | 0.010 |
Why?
|
Sodium | 2 | 1982 | 1588 | 0.010 |
Why?
|
Permeability | 1 | 1980 | 721 | 0.010 |
Why?
|
United States | 2 | 2017 | 72292 | 0.010 |
Why?
|
Child, Preschool | 3 | 2016 | 42193 | 0.010 |
Why?
|
Child | 5 | 2016 | 80089 | 0.010 |
Why?
|
Platelet Function Tests | 1 | 1980 | 271 | 0.010 |
Why?
|
Norepinephrine | 1 | 1980 | 898 | 0.010 |
Why?
|
Binding Sites, Antibody | 1 | 1978 | 337 | 0.010 |
Why?
|
Thyroid Gland | 1 | 1964 | 1170 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 54364 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1993 | 12966 | 0.010 |
Why?
|
Erythrocyte Membrane | 1 | 1979 | 439 | 0.010 |
Why?
|
Anemia | 1 | 2007 | 1504 | 0.010 |
Why?
|
Cell Lineage | 1 | 2006 | 2553 | 0.010 |
Why?
|
Autoantibodies | 3 | 1984 | 2115 | 0.010 |
Why?
|
RNA, Messenger | 2 | 1990 | 12759 | 0.010 |
Why?
|
Models, Structural | 1 | 1997 | 340 | 0.010 |
Why?
|
Serum Albumin | 1 | 1980 | 673 | 0.010 |
Why?
|
Xanthine Oxidase | 1 | 1977 | 69 | 0.010 |
Why?
|
Xanthines | 1 | 1977 | 120 | 0.010 |
Why?
|
Static Electricity | 1 | 1997 | 261 | 0.010 |
Why?
|
Phorbol Esters | 1 | 1996 | 108 | 0.010 |
Why?
|
Platelet Factor 3 | 1 | 1976 | 2 | 0.010 |
Why?
|
Spleen | 2 | 1974 | 2286 | 0.010 |
Why?
|
Cryoglobulins | 1 | 1976 | 58 | 0.010 |
Why?
|
Chemical Precipitation | 1 | 1976 | 175 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 1985 | 4845 | 0.010 |
Why?
|
Methylprednisolone | 1 | 1978 | 385 | 0.010 |
Why?
|
Peptide Fragments | 2 | 1986 | 5109 | 0.010 |
Why?
|
Complement C3 | 1 | 1978 | 434 | 0.010 |
Why?
|
Research | 1 | 1964 | 1977 | 0.010 |
Why?
|
Organ Culture Techniques | 2 | 1983 | 794 | 0.010 |
Why?
|
Epithelium | 1 | 1980 | 1603 | 0.010 |
Why?
|
Hormones | 1 | 1980 | 869 | 0.010 |
Why?
|
Electric Conductivity | 1 | 1976 | 405 | 0.010 |
Why?
|
Clinical Trials as Topic | 2 | 1985 | 7995 | 0.010 |
Why?
|
Swine | 1 | 1985 | 5908 | 0.010 |
Why?
|
Ferric Compounds | 1 | 1977 | 378 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 1996 | 659 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 10429 | 0.010 |
Why?
|
Freezing | 2 | 1972 | 311 | 0.010 |
Why?
|
Blood Volume | 1 | 1976 | 547 | 0.010 |
Why?
|
Tetrazolium Salts | 1 | 1974 | 92 | 0.010 |
Why?
|
Superoxide Dismutase | 1 | 1977 | 593 | 0.010 |
Why?
|
Chlorides | 1 | 1977 | 665 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 1985 | 3031 | 0.010 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1996 | 944 | 0.010 |
Why?
|
Chromatography, DEAE-Cellulose | 1 | 1973 | 81 | 0.010 |
Why?
|
Antigen-Antibody Reactions | 1 | 1974 | 340 | 0.010 |
Why?
|
Phlebitis | 1 | 1974 | 35 | 0.010 |
Why?
|
Antibody Formation | 2 | 1984 | 1390 | 0.010 |
Why?
|
Adsorption | 1 | 1974 | 197 | 0.010 |
Why?
|
Immunologic Techniques | 1 | 1974 | 212 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2022 | 80583 | 0.010 |
Why?
|
Polyethylene Glycols | 1 | 1979 | 1182 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 1979 | 15498 | 0.010 |
Why?
|
Tritium | 1 | 1973 | 706 | 0.010 |
Why?
|
Metals | 1 | 1997 | 719 | 0.010 |
Why?
|
Blood Circulation | 1 | 1974 | 248 | 0.010 |
Why?
|
Cold Temperature | 1 | 1976 | 785 | 0.010 |
Why?
|
Phospholipids | 1 | 1976 | 787 | 0.010 |
Why?
|
Informed Consent | 1 | 1978 | 1007 | 0.010 |
Why?
|
Exercise Test | 1 | 1980 | 2127 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 1981 | 6188 | 0.010 |
Why?
|
Aging | 1 | 2011 | 8700 | 0.010 |
Why?
|
Smallpox Vaccine | 1 | 1972 | 77 | 0.010 |
Why?
|
Dimethyl Sulfoxide | 1 | 1972 | 251 | 0.010 |
Why?
|
Cryoprotective Agents | 1 | 1972 | 128 | 0.010 |
Why?
|
Boston | 1 | 2004 | 9313 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2007 | 9417 | 0.010 |
Why?
|
Pituitary Gland | 2 | 1980 | 635 | 0.010 |
Why?
|
Middle Aged | 8 | 1988 | 220603 | 0.010 |
Why?
|
Hypotonic Solutions | 1 | 1970 | 48 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 1996 | 1674 | 0.010 |
Why?
|
Translocation, Genetic | 1 | 1996 | 1392 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 1989 | 11874 | 0.010 |
Why?
|
Densitometry | 1 | 1970 | 151 | 0.010 |
Why?
|
Hot Temperature | 1 | 1977 | 1438 | 0.010 |
Why?
|
Glycosylation | 1 | 1993 | 1098 | 0.010 |
Why?
|
Osmotic Pressure | 1 | 1970 | 138 | 0.010 |
Why?
|
Syndrome | 1 | 1976 | 3268 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 1976 | 1988 | 0.010 |
Why?
|
Down-Regulation | 1 | 1996 | 2916 | 0.010 |
Why?
|
Automation | 1 | 1971 | 585 | 0.010 |
Why?
|
Immunoglobulins | 1 | 1972 | 850 | 0.000 |
Why?
|
Monocytes | 1 | 1978 | 2565 | 0.000 |
Why?
|
Fatty Acids | 1 | 1976 | 1808 | 0.000 |
Why?
|
Cyclophosphamide | 1 | 1973 | 2218 | 0.000 |
Why?
|
DNA, Recombinant | 1 | 1988 | 455 | 0.000 |
Why?
|
Haplorhini | 1 | 1988 | 525 | 0.000 |
Why?
|
Blood Pressure | 1 | 1983 | 8473 | 0.000 |
Why?
|
Estrogens | 1 | 1974 | 1521 | 0.000 |
Why?
|
Cerebrovascular Disorders | 1 | 1974 | 1474 | 0.000 |
Why?
|
Cell Fractionation | 1 | 1987 | 249 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1978 | 10754 | 0.000 |
Why?
|
Lymphocytes | 1 | 1973 | 2604 | 0.000 |
Why?
|
Prolactin | 1 | 1967 | 625 | 0.000 |
Why?
|
Gastrointestinal Diseases | 1 | 1974 | 1202 | 0.000 |
Why?
|
Subcellular Fractions | 2 | 1976 | 531 | 0.000 |
Why?
|
Plasma | 1 | 1967 | 586 | 0.000 |
Why?
|
Prognosis | 1 | 1985 | 29601 | 0.000 |
Why?
|
Blood Transfusion, Autologous | 2 | 1976 | 130 | 0.000 |
Why?
|
Adolescent | 3 | 1984 | 88247 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1977 | 12333 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 1985 | 39062 | 0.000 |
Why?
|
Biological Transport | 1 | 1967 | 2089 | 0.000 |
Why?
|
Rats | 2 | 1980 | 23716 | 0.000 |
Why?
|
Rodentia | 1 | 1983 | 261 | 0.000 |
Why?
|
Prostaglandin Endoperoxides, Synthetic | 1 | 1981 | 58 | 0.000 |
Why?
|
Drug Antagonism | 1 | 1981 | 51 | 0.000 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1973 | 2152 | 0.000 |
Why?
|
Phosphorylation | 1 | 1991 | 8311 | 0.000 |
Why?
|
Cations | 1 | 1980 | 238 | 0.000 |
Why?
|
Phentolamine | 1 | 1978 | 102 | 0.000 |
Why?
|
Calcium Phosphates | 1 | 1980 | 171 | 0.000 |
Why?
|
DNA Replication | 1 | 1985 | 1414 | 0.000 |
Why?
|
Calcium | 1 | 1991 | 5717 | 0.000 |
Why?
|
Culture Media | 1 | 1980 | 895 | 0.000 |
Why?
|
Connective Tissue | 1 | 1980 | 419 | 0.000 |
Why?
|
Aged | 5 | 1984 | 169092 | 0.000 |
Why?
|
Drug Tolerance | 1 | 1978 | 367 | 0.000 |
Why?
|
Adenine | 1 | 1982 | 985 | 0.000 |
Why?
|
Mice | 2 | 1981 | 81368 | 0.000 |
Why?
|
Plasma Substitutes | 1 | 1976 | 57 | 0.000 |
Why?
|
Adenosine | 1 | 1981 | 805 | 0.000 |
Why?
|
Phosphatidylethanolamines | 1 | 1976 | 129 | 0.000 |
Why?
|
Infusions, Parenteral | 1 | 1976 | 397 | 0.000 |
Why?
|
Hemostasis, Surgical | 1 | 1976 | 126 | 0.000 |
Why?
|
Phosphatidylcholines | 1 | 1976 | 405 | 0.000 |
Why?
|
Hematocrit | 1 | 1976 | 623 | 0.000 |
Why?
|
Methods | 1 | 1973 | 1065 | 0.000 |
Why?
|
Regional Blood Flow | 1 | 1976 | 1496 | 0.000 |
Why?
|
Osmotic Fragility | 1 | 1972 | 35 | 0.000 |
Why?
|
Ligands | 1 | 1978 | 3268 | 0.000 |
Why?
|
False Positive Reactions | 1 | 1973 | 957 | 0.000 |
Why?
|
Autoradiography | 1 | 1972 | 728 | 0.000 |
Why?
|
Hemolysis | 1 | 1972 | 415 | 0.000 |
Why?
|
Angiography | 1 | 1973 | 1595 | 0.000 |
Why?
|
Osmosis | 1 | 1967 | 103 | 0.000 |
Why?
|
Potassium | 1 | 1972 | 1311 | 0.000 |
Why?
|
Electrocardiography | 1 | 1981 | 6346 | 0.000 |
Why?
|
Survival | 1 | 1967 | 161 | 0.000 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1972 | 2495 | 0.000 |
Why?
|
Hemoglobins | 1 | 1972 | 1524 | 0.000 |
Why?
|
Surgical Procedures, Operative | 1 | 1976 | 1924 | 0.000 |
Why?
|
Erythrocytes | 1 | 1972 | 2410 | 0.000 |
Why?
|
Skin | 1 | 1976 | 4472 | 0.000 |
Why?
|